Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Feedback from patients, caregivers, and others will help shape studies testing the safety and effectiveness of potential Long COVID treatments.
A study from Mass General Brigham followed 3,659 adults to identify eight different paths that Long COVID can take, based on symptoms and length of illness. The results will inform future studies and possible treatments for Long COVID.
During the October 28 RECOVER Research Review (R3) seminar, RECOVER researchers Samantha Russell, MD, and Janko Nikolich, MD, PhD, MSc, presented their published papers on Long COVID in older adults. Dr. Russell discussed a review article on Long COVID in older adults, which was published in 2024. Dr. Nikolich shared findings from the RECOVER observational study that compared Long COVID symptoms across different age groups. Quinn Barnette, MPH, facilitated the discussion.
Results from the RECOVER-NEURO clinical trial were published in the journal JAMA Neurology. The trial focused on symptoms of cognitive dysfunction associated with Long COVID, including brain fog, trouble focusing, and thinking clearly.
RECOVER pathobiologists have designed a large, collaborative, and innovative study that can help to develop diagnostics for specific types of Long COVID.
A mother living with Long COVID and her daughter, who supports her as a caregiver, share their motivations to join the RECOVER Initiative as Representatives.
Teams from 4 RECOVER clinical trial sites share their recruitment strategies and their efforts to reach out to and share research opportunities with their local communities.
During the RECOVER Research Review (R3) Seminar on October 14, RECOVER researchers Candace Feldman, MD, MPH, ScD, and Kay Rhee, MD, MSc, MA, shared new findings from the initiative’s adult and pediatric observational studies about how social and economic challenges influence the risk of developing Long COVID. RECOVER Representative and coauthor of the adult study paper, Brittany D. Taylor, MPH, joined them to share her experience in collaborating with the paper’s other authors. Elizabeth Karlson, MD, MS, who was also a coauthor of the adult study paper, facilitated the discussion and Q&A session.
RECOVER researchers and experts from BioData Catalyst® will walk through tools that other researchers may use for their studies of RECOVER data, from determining feasibility to completing the study.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.